Completed PHASE3 INTERVENTIONAL 2-arm NCT00217100

A Multivitamin Comparison Study in Kidney Transplant Recipients.

Folic Acid for Vascular Outcome Reduction in Transplantation.

Sponsor: Mayo Clinic

Updated 6 times since 2017 Last updated: Apr 23, 2012 Started: Oct 31, 2004 Primary completion: Feb 28, 2010 Completion: Feb 28, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00217100, this PHASE3 trial focuses on Kidney Transplant Recipients and remains completed. Sponsored by Mayo Clinic, it has been updated 6 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic
Ohio State University
University of Alabama at Birmingham
University of California, San Francisco
University of Wisconsin, Madison

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States